Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Bjerkholt currently holds 36,355 shares of SUNESIS PHARMACEUTICALS INC (SNSS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Bjerkholt has been a net seller of SNSS stock. They have purchased $1.1M and sold $2.5M worth of shares.
Eric Bjerkholt's most recent insider trade was on Aug 11, 2026, when they sold 6,001 shares at $99.90 per share.
Eric Bjerkholt serves as Executive at SUNESIS PHARMACEUTICALS INC (SNSS). They have executed 111 insider transactions totaling $3.6M over their tenure at the company.
Eric Bjerkholt holds the position of Executive at SUNESIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Eric Bjerkholt has shown a selling trading pattern, with $1.1M in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Bjerkholt was on Sep 12, 2025, when they sold $728.0K worth of MIRM shares. This transaction involved 9,578 shares at $76.01 per share.
Eric Bjerkholt currently owns 36,355 shares of SUNESIS PHARMACEUTICALS INC (SNSS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Bjerkholt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Bjerkholt has 111 Form 4 filings on record as an insider at SUNESIS PHARMACEUTICALS INC.
Set alerts for Eric Bjerkholt and 40,000+ other insiders.